SUCCESSFUL FERTILITY RESTORATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引:15
|
作者
Gharwan, Helen [1 ]
Neary, Nicola M. [2 ]
Link, Mary [3 ]
Hsieh, Matthew M. [3 ]
Fitzhugh, Courtney D. [3 ]
Sherins, Richard J. [4 ]
Tisdale, John F. [3 ,4 ]
机构
[1] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
[2] St George Hosp, Dept Endocrinol, London, England
[3] NHLBI, Mol & Clin Hematol Branch, Bethesda, MD 20892 USA
[4] Columbia Fertil Associates, Washington, DC USA
关键词
BONE-MARROW-TRANSPLANTATION; IRON OVERLOAD; DISEASE; HYPOGONADISM; PARAMETERS; HYDROXYUREA; RECIPIENTS; RADIATION; THERAPY;
D O I
10.4158/EP13474.CR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Myeloablative conditioning regimens given prior to hematopoietic stem cell transplantation (HSCT) frequently cause permanent sterility in men. In patients with sickle cell disease (SCD) we use a nonmyeloablative regimen with sirolimus, alemtuzumab, and low-dose total-body irradiation (300 centigrays) with gonadal shielding preceding allogeneic HSCT. We report here the restoration of azoospermia in a patient with SCD after allogeneic HSCT. We discuss the impact of our patient's underlying chronic medical conditions and the therapies he had received (frequent blood transfusions, iron chelating drugs, ribavirin, hydroxyurea, opioids), as well as the impact of the nonmyeloablative conditioning regimen on male gonadal function, and we review the literature on this topic. Methods: We determined the patient's reproductive hormonal values and his semen parameters before, during, and after HSCT and infertility treatment. In addition, we routinely measured his serum laboratory parameters pertinent to SCD and infertility, such as iron and ferritin levels. A karyotype analysis was performed to assess the potential presence of Klinefelter syndrome. Finally, imaging studies of the patient's brain and testes were done to rule out further underlying pathology. Results: A 42-year-old man with SCD, transfusional iron overload, and hepatitis C underwent a nonmyeloablative allogeneic HSCT. One year later he desired to father a child but was found to be azoospermic in the context of hypogonadotropic hypogonadism. Restoration of fertility was attempted with human chorionic gonadotropin (2,000 IU) plus human menopausal gonadotropin (75 IU follicle-stimulating hormone) injected subcutaneously 3 times weekly. Within 6 months of treatment, the patient's serum calculated free testosterone value normalized, and his sperm count and sperm motility improved. After 10 months, he successfully initiated a pregnancy through intercourse. The pregnancy was uncomplicated, and a healthy daughter was delivered naturally at term. Conclusion: Despite exposure to several gonadotoxins, transfusional iron overload and nonmyeloablative conditioning with radiation causing severe testicular atrophy suggesting extensive damage to seminiferous tubules and possibly Leydig cells, gonadotropins were efficacious in restoring our patient's reproductive capability.
引用
收藏
页码:E157 / E161
页数:5
相关论文
共 50 条
  • [1] Erythrocytosis after allogeneic hematopoietic stem cell transplantation
    Hino, Yutaro
    Doki, Noriko
    Kurosawa, Shuhei
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Hattori, Kenichiro
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [2] Jaundice After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendizabal, Manuel
    Chen, Terina
    Reddy, K. Rajender
    HEPATOLOGY, 2009, 50 (06) : 2044 - 2045
  • [3] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Q. Jiang
    B. H. Zhang
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 504 - 506
  • [4] Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation
    Robinson, Tracy
    Streu, Erin
    ONCOLOGY NURSING FORUM, 2015, 42 (05) : 558 - 561
  • [5] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Q.
    Zhang, B. H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) : 504 - 506
  • [6] Plasticity after allogeneic hematopoietic stem cell transplantation
    Rovo, Alicia
    Gratwohl, Alois
    BIOLOGICAL CHEMISTRY, 2008, 389 (07) : 825 - 836
  • [7] Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendoza, Maria Alejandra
    Imlay, Hannah
    VIRUSES-BASEL, 2025, 17 (03):
  • [8] Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Blaser, Bradley W.
    Kim, Haesook
    Plutzky, Jorge
    Alyea, Edwin, III
    Ho, Vincent
    Cutler, Corey
    Armand, Philippe
    Koreth, John
    Antin, Joseph H.
    Soiffer, Robert
    BLOOD, 2010, 116 (21) : 1419 - 1419
  • [9] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [10] Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients
    Nabhan, Samir K.
    Bitencourt, Marco A.
    Duval, Michel
    Abecasis, Manuel
    Dufour, Carlo
    Boudjedir, Karim
    Rocha, Vanderson
    Socie, Gerard
    Passweg, Jakob
    Goi, Kumiko
    Sanders, Jean
    Snowden, John
    Yabe, Hiromasa
    Pasquini, Ricardo
    Gluckman, Eliane
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1783 - 1787